文献速递母胎医学

利用半导体测序平台经孕妇血浆无需父母单倍型分析无创检测血红蛋白巴特水肿胎儿

Noninvasive prenatal detection of hemoglobin Bart hydrops fetalis via maternal plasma dispensed with parental haplotyping using the semiconductor sequencing platform.
PubMed 文献 · Am J Obstet Gynecol · 2019-08-05

本研究纳入30家医院192,173对夫妇,其中878对夫妇双方均为东南亚型α-地中海贫血携带者,采用目标捕获测序和贝叶斯方法对孕妇血浆游离胎儿DNA进行基因分型,以绒毛取样、羊膜腔穿刺或脐血穿刺的缺口PCR为金标准,无创方法在训练集敏感度98.81%、特异度94.72%,在测试集敏感度100%、特异度99.31%。

要点

  • 双方均为东南亚型α-地中海贫血携带者的孕妇中,无创方法检测血红蛋白巴特水肿胎儿训练集敏感度98.81%、特异度94.72%。
  • 测试集敏感度100%、特异度99.31%,并可100%检出13/18/21三体样本。
  • 该方法可在单管孕妇血浆中同时筛查α-地中海贫血母体基因型、胎儿13/18/21染色体非整倍体及巴特水肿胎儿。

核心结论

  • 该方法为单管孕妇血浆中α-地中海贫血母体基因分型、胎儿13/18/21染色体非整倍体及血红蛋白巴特水肿胎儿检测的早期筛查提供了可能。

研究设计与样本

  • 研究纳入30家医院共192,173对夫妇,招募其中双方均检测为东南亚型α-地中海贫血携带者(-/αα)的878对夫妇。
  • 以绒毛取样、羊膜腔穿刺或脐血穿刺的缺口聚合酶链反应为金标准进行产前诊断。
  • 采用目标捕获测序和贝叶斯方法对孕妇血浆游离胎儿DNA进行基因分型。

主要发现

  • 无创方法在训练集敏感度98.81%、特异度94.72%,在测试集敏感度100%、特异度99.31%。
  • 该方法以100%敏感度识别全部885例东南亚型携带者母体样本和36例三体样本中的T13、T18、T21。
  • T18特异度99.89%(917例中1例假阳性),T21特异度99.88%(888例中1例假阳性)。

局限性

  • 原文指出既往利用胎儿游离DNA筛查巴特水肿胎儿的研究例数仍相对较少,需要大样本临床试验。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Thalassemia is one of the most common monogenetic diseases in the south of China and Southeast Asia. Hemoglobin Bart's hydrops fetalis syndrome was caused by a homozygous Southeast Asian deletion (-/-) in the HBA gene. Few studies have proved the potential of screen for Bart's hydrops fetalis using fetal cell-free DNA. However, the number of cases is still relatively small. Clinical trials of large samples would be needed. OBJECTIVE: In this study, we aimed to develop a noninvasive method of target-captured sequencing and genotyping by the Bayesian method using cell-free fetal DNA to identify the fetal genotype in pregnant women who are at risk of having hemoglobin Bart hydrops fetalis in a large-scale study. STUDY DESIGN: In total, 192,173 couples from 30 hospitals were enrolled in our study and 878 couples were recruited, among whom both the pregnant women and their husbands were detected to be carriers of Southeast Asian type (-/αα) of α-thalassemia. Prenatal diagnosis was performed by chorionic villus sampling, amniocentesis, or cordocentesis using gap-polymerase chain reaction considered as the golden standard. RESULTS: As a result, we found that the sensitivity and specificity of our noninvasive method were 98.81% and 94.72%, respectively, in the training set as well as 100% and 99.31%, respectively, in the testing set. Moreover, our method could identify all of 885 maternal samples with the Southeast Asian carrier and 36 trisomy samples with 100% of sensitivity in T13, T18, and T21 and 99.89% (1 of 917) and 99.88% (1 of 888) of specificity in T18 and T21, respectively. CONCLUSION: Our method opens the possibility of early screening for maternal genotyping of α-thalassemia, fetal aneuploidies in chromosomes 13/18/21, and hemoglobin Bart hydrops fetalis detection in 1 tube of maternal plasma.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Yang J, Peng CF, Qi Y, et al. Noninvasive prenatal detection of hemoglobin Bart hydrops fetalis via maternal plasma dispensed with parental haplotyping using the semiconductor sequencing platform. Am J Obstet Gynecol. 2019. PMID: 31394068. doi:10.1016/j.ajog.2019.07.044

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。